How cells read TGF-β signals

Nature Reviews Molecular Cell Biology

Volumn 1, Issue 3, 2000, Pages 169-178

  Massagué, Joan ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ANIMAL; BIOLOGICAL MODEL; CELL DIVISION; CHEMISTRY; HUMAN; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CELL DIVISION; HUMANS; MAP KINASE SIGNALING SYSTEM; MODELS, BIOLOGICAL; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 0034574298     PISSN: 14710072     EISSN: None     Source Type: Journal    
DOI: 10.1038/35043051     Document Type: Review

References (109)

1. Massagué, J. TGFβ signal transduction. Annu. Rev. Biochem. 67, 753-791 (1998).
2. Schier, A. F. & Shen, M. M. Nodal signalling in vertebrate development. Nature 403, 385-389 (2000).
3. Whitman, M. SMADs and early developmental signaling by the TGFβ superfamily. Genes Dev. 12, 2445-2462 (1998).
4. Massagué, J., Blain, S. W. & Lo, R. S. TGF-β signaling in growth control, cancer and heritable disorders. Cell 103, 295-309 (2000).
5. Wrana, J. L., Attisano, L., Wieser, R., Ventura, F. & Massagué, J. Mechanism of activation of the TGF-β receptor. Nature 370, 341-347 (1994). Elucidation of the mechanisms of receptor activation based on a combined biochemical and genetic approach.
6. Wieser, R., Wrana, J. L. & Massagué, J. GS domain mutations that constitutively activate TβR-1, the downstream signaling component in the TGF-β receptor complex. EMBO J. 14, 2199-2208 (1995).
7. Lo, R. S. & Massagué, J. Ubiquitin-dependent degradation of TGF-β-activated SMAD2. Nature Cell Biol. 1, 472-478 (1999).
8. Zhu, H., Kavsak, P., Abdollah, S., Wrana, J. L. & Thomsen, G. H. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature 400, 687-693 (1999).
9. Raftery, L. A. & Sutherland, D. J. TGF-β family signal transduction in Drosophila development: from Mad to SMADs. Dev. Biol. 210, 251-268 (1999). A chronicle of the discovery of MAD, the founding member of the SMAD family.
10. Xu, L., Chen, Y. G. & Massagué, J. The nuclear import function of SMAD2 is masked by SARA and unmasked by TGFβ-dependent phosphorylation. Nature Cell Biol. 2, 559-562 (2000).
11. Hahn, S. A. et al. DPC4, a candidate tumor suppressor gene at human chromosome 18q21.1. Science 271, 350-353 (1996).
12. Lagna, G., Hata, A., Hemmati-Brivanlou, A. & Massagué, J. Partnership between DPC4 and SMAD proteins in TGFβ signalling pathways. Nature 383, 832-836 (1996). Reveals the role of SMAD4 as a shared partner of receptor-activated SMADs.
13. Chen, X. et al. SMAD4 and FAST-1 in the assembly of activin-responsive factor. Nature 389, 85-89 (1997). Delineates the role of FAST as a SMAD DNA-binding cofactor
14. Liu, F., Pouponnot, C. & Massagué, J. Dual role of the SMAD4/DPC4 tumor suppressor in TGFβ-inducible transcriptional responses. Genes Dev. 11, 3157-3167 (1997).
15. de Caestecker, M. P. et al. The SMAD4 activation domain (SAD) is a proline-rich, p300-dependent transcriptional activation domain. J. Biol. Chem. 275, 2115-2122 (2000).
16. Janknecht, R., Wells, N. J. & Hunter, T. TGF-β-stimulated cooperation of SMAD proteins with the coactivators CBP/p300. Genes Dev. 12, 2114-2119 (1998).
17. Massagué, J. & Wotton, D. Transcriptional control by the TGF-β/SMAD signaling system. EMBO J. 19, 1745-1754 (2000).
18. Yahata, T. et al. The MSG1 non-DNA-binding transactivator binds to the p300/CBP coactivators, enhancing their functional link to the SMAD transcription factors. J. Biol. Chem. 275, 8825-6834 (2000).
19. Tsukazaki, T., Chiang, T. A., Davison, A. F., Attisano, L. & Wrana, J. L. SARA, a FYVE domain protein that recruits SMAD2 to the TGFβ receptor. Cell 95, 779-791 (1998). Identification of a cytoptasmic regulator of SMAD movement to TGF-β receptors.
20. Conti, E., Uy, M., Leighton, L, Blobel, G. & Kuriyan, J. Cristallographic analysis of the recognition of a nuclear localization signal by the nuclear import factor karyopherin-α. Cell 94, 193-204 (1998).
21. Xiao, Z., Liu, X. & Lodish, H. F. Importin-β mediates nuclear translocation of SMAD 3. J. Biol. Chem. 275, 23425-23428 (2000).
22. Morén, A., Itoh, S., Moustakas, A., Dijke, P. & Heldin, C. H. Functional consequences of tumorigenic missense mutations in the amino-terminal domain of SMAD4. Oncogene 19, 4396-4404 (2000).
23. Jones, J. B. & Kern, S. E. Functional mapping of the MH1 DNA-binding domain of DPC4/SMAD4. Nucleic Acids Res. 28, 2363-2368 (2000).
24. Shi, Y. et al. Crystal structure of a SMAD MH1 domain bound to DNA: Insights on DNA-binding in TGF-β signaling. Cell 94, 585-594 (1998).
25. Watanabe, M., Masuyama, N., Fukuda, M. & Nishida, E. Regulation of intracellular dynamics of SMAD4 by its leucine-rich nuclear export signal. EMBO Rep. 1, 176-182 (2000).
26. Masuyama, N., Hanafusa, H., Kusakabe, M., Shibuya, H. & Nishida, E. Identification of two SMAD4 proteins in Xenopus. Their common and distinct properties. J. Biol. Chem. 274, 12163-12170 (1999).
27. Chen, Y. G. et al. Determinants of specificity in TGF-β signal transduction. Genes Dev. 12, 2144-2152 (1998).
28. Graft, J. M., Bansal, A. & Melton, D. A. Xenopus Mad proteins transduce distinct subsets of signals for the TGF-β superfamily. Cell 85, 479-487 (1996). The opposing but complementary roles of SMAD1 and SMAD2 are revealed.
29. Baker, J. & Harland, R. M. A novel mesoderm inducer, mMadr-2, functions in the activin signal transduction pathway. Genes Dev. 10, 1880-1889 (1996).
30. Rodriguez Esteban, C. et al. The novel Cer-like protein Caronte mediates the establishment of embryonic left-right asymmetry. Nature 401, 243-251 (1999).
31. Yokouchi, Y., Vogan, K. J., Pearse, R. V. & Tabin, C. J. Antagonistic signaling by Caronte, a novel Cerberus-related gene, establishes left-right asymmetric gene expression. Cell 98, 573-583 (1999).
32. Saijoh, Y. et al. Left-right assymetric expression of lefty2 and nodal is induced by a signaling pathway that includes the transcription factor FAST2. Mol. Cell 5, 35-47 (2000). References 31 and 32 report on regulation of BMP activity by Hedgehog in the extracellular space.
33. Feng, X. H. & Derynck, R. A kinase subdomain of transforming growth factor-β (TGF-β) type I receptor determines the TGF-β intracellular signaling activity. EMBO J. 16, 3912-3922 (1997).
34. Lo, R. S., Chen, Y. G., Shi, Y. G., Pavletich, N. & Massagué, J. The L3 loop: a structural motif determining specific interactions between SMAD proteins and TGF-β receptors. EMBO J. 17, 996-1005 (1998).
35. Yagi, K. et al. Alternatively spliced variant of SMAD2 lacking exon 3. Comparison with wild-type SMAD2 and SMAD3. J. Biol.Chem. 274, 703-709 (1999).
36. Ashcroft, G. S. et al. Mice lacking SMAD3 show accelerated wound healing and an impaired local inflammatory response. Nature Cell Biol. 1, 260-266 (1999).
37. Denissova, N. G., Pouponnot, C., Long, J., He, D. & Liu, F. Transforming growth factor β-inducible independent binding of SMAD to the SMAD7 promoter. Proc. Natl Acad. Sci. USA 97, 6397-6402 (2000).
38. Hata, A. et al. OAZ uses distinct DMA- and protein-binding zinc fingers in separate BMP-SMAD and Olf signaling pathways. Cell 100, 229-240 (2000).
39. Germain, S., Howell, M., Esslemont, G. M. & Hill, C. S. Homeodomain and winged-helix transcription factors recruit activated SMADs to distinct promoter elements via a common SMAD interaction motif. Genes Dev. 14, 435-451 (2000).
40. Yeo, C. Y. Chen, X. & Whitman, M. The role of FAST-1 and SMADs in transcriptional regulation by activin during early Xenopus embryogenesis. J. Biol. Chem. 274, 26584-26590 (1999).
41. Hua, X., Miller, Z. A., Wu, G., Shi, Y. & Lodish, H. F. Specificity in transforming growth factor β-induced transcription of the plasminogen activator inhibitor-1 gene: interactions of promoter DNA, transcription factor muE3, and SMAD proteins. Proc. Natl Acad. Sci. USA 96, 13130-13135 (1999).
42. Chen, X., Rubock, M. J. & Whitman, M. A transcriptional partner of MAD proteins in TGF-β signalling. Nature 383, 691-696 (1996).
43. Zhang, Y., Feng, X. H. & Derynck, R. SMAD3 and SMAD4 cooperate with c-Jun/c-Fos to mediate TGF-β-induced transcription. Nature 394, 909-913 (1998).
44. Tsuji, K., Ito, Y. & Noda, M. Expression of the PEBP2αA/AML3/CBFA1 gene is regulated by BMP4/7 heterodimer and its overexpression suppresses type I collagen and osteocalcin gene expression in osteoblastic and nonosteoblastic mesenchymal cells. Bone 22, 87-92 (1998).
45. Pardali, E. et al. SMAD and AML proteins synergistically confer transforming growth factor β1 responsiveness to human germ-line IgA genes. J. Biol. Chem. 275, 3552-3560 (2000).
46. Hanai, J. et al. Interaction and functional cooperation of PEBP2/CBF with SMADs. Synergistic induction of the immunoglobulin germline Cα promoter. J. Biol. Chem. 274, 31577-31582 (1999).
47. Nishita, M. et al. Interaction between Wnt and TGF-β signalling pathways during formation of Spemann's organizer. Nature 403, 781-785 (2000). Evidence for direct cooperation between mediators of the TGF-β and Wnt pathways.
48. Labbe, E., Letamendia, A. & Attisano, L. Association of SMADs with lymphoid enhancer binding factor 1/T cell-specific factor mediates cooperative signaling by the transforming growth factor-β and wnt pathways. Proc. Natl Acad. Sci. USA 97, 8358-8363 (2000).
49. Wotton, D., Lo, R. S., Lee, S. & Massagué, J. A SMAD transcriptional corepressor. Cell 97, 29-39 (1999). The first SMAD transcriptional corepressor and its competition with co-activators.
50. Luo, K. et al. The ski oncoprotein interacts with the SMAD proteins to repress TGF-β signaling. Genes Dev. 13, 2196-2206 (1999).
51. Sun, Y., Liu, X., Ng-Eaton, E., Lodish, H. F. & Weinberg, R. A. SnoN and Ski protooncoproteins are rapidly degraded in response to transforming growth factor-β signaling. Proc. Natl Acad. Sci. USA 96, 12442-12447 (1999). References 50 and 51 report on the proto-oncogene SKI as a corepressor of SMADs in the basal state.
52. Perou, C. M. et al. Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc. Natl Acad. Sci. USA 96, 9212-9217 (1999).
53. Stroschein, S. L., Wang, W., Zhou, S., Zhou, Q. & Luo, K. Negative feedback regulation of TGF-b signaling by the SnoN oncoprotein. Science 286, 771-774 (1999).
54. Lo, R. S., Wotton, D. & Massagué, J. EGF signaling via Ras stabilizes the SMAD transcriptional corepressor TGIF. EMBO J. (in the press).
55. Gripp, K. W. et al. Mutations in TGIF cause holoprosencephaly and link nodal signalling to human neural axis determination. Nature Genet. 25, 205-208 (2000).
56. Sampath, K. et al. Induction of the zebrafish ventral brain and floorplate requires cyclops/nodal signalling. Nature 395, 185-189 (1998).
57. Nomura, M. & Li, E. SMAD2 role in mesoderm formation, left-right patterning and craniofacial development. Nature 393, 786-790 (1998).
58. Hocevar, B. A., Brown, T. L. & Howe, P. H. TGF-β induces fibronectin synthesis through a c-Jun N-terminal kinase-dependent, SMAD4-independent pathway. EMBO J. 18, 1345-1356 (1999). An example of rapid activation of JNK by TGF-β and its effects on gene expression.
59. Hanafusa, H. et al. Involvement of the p38 mitogen-activated protein kinase pathway in transforming growth factor-β-induced gene expression. J. Biol. Chem. 274, 27161-27167 (1999).
60. Sano, Y. et al. ATF-2 is a common nuclear target of SMAD and TAK1 pathways in transforming growth factor-β signaling. J. Biol. Chem. 274, 8949-8957 (1999).
61. Takatsu, Y. et al. TAK1 participates in c-Jun N-terminal kinase signaling during Drosophila development. Mol. Cell. Biol. 20, 3015-3026 (2000).
62. Shibuya, H. et al. TAB1: an activator of the TAK1 MAPKKK in TGF-β signal transduction. Science 272, 1179-1182 (1996).
63. Yamaguchi, K. et al. XIAP, a cellular member of the inhibitor of apoptosis protein family, links the receptors to TAB1-TAK1 in the BMP signaling pathway. EMBO J. 18, 179-187 (1999).
64. Engel, M. E., McDonnell, M. A. Law, B. K. & Moses, H. L. Interdependent SMAD and JNK signaling in transforming growth factor-β-mediated transcription. J. Biol. Chem. 274, 37413-37420 (1999).
65. Wong, C. et al. SMAD3-SMAD4 and AP-1 complexes synergize in transcriptional activation of the c-Jun promoter by transforming growth factor-β. Mol. Cell. Biol. 19, 1821-1830 (1999).
66. Massagué, J. & Chen, Y. G. Controlling TGF-β signaling. Genes Dev. 14, 627-644 (2000).
67. ten Dijke, P., Miyazono, K. & Heldin, C. H. Signaling inputs converge on nuclear effectors in TGF-β signaling. Trends Biochem. Sci. 25, 64-70 (2000).
68. Tanimoto, H., Itoh, S., ten Dijke, P. & Tabata, T. Hedgehog creates a gradient of DPP activity in Drosophila wing imaginai discs. Mol. Cell 5, 59-71 (2000). Crosstalk between the Hedgehog and the BMP system at the level of Decapentaplegic receptors.
69. Hayashi, H. et al. The MAD-related protein SMAD7 associates with the TGFβ receptor and functions as an antagonist of TGFβ signaling. Cell 89, 1165-1173 (1997).
70. Nakao, A. et al. Identification of SMAD7, a TGFβ-inducible antagonist of TGF-β signaling. Nature 389, 631-635 (1997). First evidence of antagonistic SMADs relaying feedback signals.
71. Ulloa, L., Doody, J. & Massagué, J. Inhibition of transforming growth factor-β/SMAD signalling by the interferon-γ/STAT pathway. Nature 397, 710-713 (1999). Negative regulation of the SMAD pathway by the STAT pathway.
72. Bitzer, M. et al. A mechanism of suppression of TGF-β/SMAD signaling by NFκB/RelA. Genes Dev. 14, 187-197 (2000).
73. Kretzschmar, M., Doody, J. & Massagué, J. Opposing BMP and EGF signalling pathway converge on the TGFβ family mediator SMAD1. Nature 389, 618-622 (1997). Negative effects of Ras/ERK pathway on SMAD function.
74. Kretzschmar, M., Doody, J., Timokhina, I. & Massagué, J. A mechanism of repression of TGF-β/SMAD signaling by oncogenic ras. Genes Dev. 13, 804-816 (1999).
75. Halfon, M. S. et al. Ras pathway specificity is determined by the integration of multiple signal-activated and tissue-restricted transcription factors. Cell 103, 63-74 (2000).
76. Onichtchouk, D. et al. Silencing of TGF-β signalling by the pseudoreceptor BAMBI. Nature 401, 480-485 (1999).
77. Tsuneizumi, K. et al. Daughters against dpp modulates dpp organizing activity in Drosophila wing development. Nature 389, 627-631 (1997).
78. Hata, A., Lagna, G., Massagué, J. & Hemmati-Brivanlou, A. SMAD6 inhibits BMP/SMAD1 signaling by specifically competing with the SMAD4 tumor suppressor. Genes Dev. 12, 186-197 (1998).
79. Yamada, M., Szendro, P. I., Prokscha, A., Schwartz, R. J. & Eichele, G. Evidence for a role of SMAD6 in chick cardiac development. Dev. Biol. 215, 48-61 (1999).
80. Zhao, J., Shi, W., Chen, H. & Warburton, D. SMAD7 and SMAD6 differentially modulate transforming growth factor-β-induced inhibition of embryonic lung morphogenesis. J. Biol. Chem. 275, 23992-23997 (2000).
81. Galvin, K. M. et al. A role for SMAD6 in development and homeostasis of the cardiovascular system. Nature Genet. 24, 171-174 (2000).
82. Imamura, T. et al. SMAD6 inhibits signalling by the TGFβ superfamily. Nature 389, 622-626 (1997).
83. López-Casillas, F., Wrana, J. L. & Massagué, J. Betaglycan presents ligand to the TGF-β signaling receptor. Cell 73, 1435-1444 (1993).
84. Lewis, K. A. et al. Betaglycan binds inhibin and can mediate functional antagonism of activin signalling. Nature 404, 411-414 (2000). The surprising versatility of a TGF-β accessory receptor is revealed.
85. Zúñiga, A., Haramis, A. P., McMahon, A. P. & Zeller, R. Signal relay by BMP antagonism controls the SHH/FGF4 feedback loop in vertebrate limb buds. Nature 401, 598-602 (1999).
86. Gazzerro, E., Gangji, V. & Canalis, E. Bone morphogenetic proteins induce the expression of noggin, which limits their activity in cultured rat osteoblasts. J. Clin. Invest. 102, 2106-2114 (1998).
87. Bilezikjian, L. M., Corrigan, A. Z., Blount, A. L. & Vale, W. W. Pituitary follistatin and inhibin subunit messenger ribonucleic acid levels are differential regulated by local and hormonal factors. Endocrinology 137, 4277-4284 (1996).
88. Crawford, S. E. et al. Thrombospondin-1 is a major activator of TGF-β1 in vivo. Cell 93, 1159-1170 (1998).
89. Green, J. B. A., New, H. V. & Smith, J. C. Responses of embryonic Xenopus cells to activin and FGF are separated by multiple dose thresholds and correspond to distinct axes of the mesoderm. Cell 71, 731-739 (1992).
90. Dyson, S. & Gurdon, J. B. The interpretation of position in a morphogen gradient as revealed by occupancy of activin receptors. Cell 93, 557-568 (1998). A saga showing the morphogenetic potential of activin signalling during Xenopus embryogenesis.
91. Zhao, J. & Buick, R. N. Regulation of transforming growth factor-β receptors in H-ras oncogene-transformed rat intestinal epithelial cells. Cancer Res. 55, 6181-6188 (1995).
92. Cornell, R. A. & Kimelman, D. Activin-mediated mesoderm induction requires FGF. Development 120, 453-462 (1994).
93. LaBonne, C. & Whitman, M. Mesoderm induction by activin requires FGF-mediated intracellular signals. Development 120, 463-472 (1994).
94. Oft, M. et al. TGF-β1 and Ha-Ras collaborate in modulating the phenotypic plasticity and invasiveness of epithelial tumor cells. Genes Dev. 10, 2462-2477 (1996). TGF-β is shown to instigate tumorigenic behaviour in transformed mammary cells.
95. Nakashima, K. et al. Synergistic signaling in fetal brain by STAT3-SMAD1 complex bridged by p300. Science 284, 479-482 (1999).
96. Shi, M. J. & Stavnezer, J. CBF α3 (AML2) is induced by TGF-β1 to bind and activate the mouse germline Igα promoter. J. Immunol. 161, 6751-6760 (1998).
97. Otto, F. et al. Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development. Cell 89, 765-771 (1997).
98. Komori, T. et al. Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89, 755-764 (1997).
99. Lee, B. et al. Missense mutations abolishing DNA binding of the osteoblast-specific transcription factor OSF2/CBFA1 in cleidocranial dysplasia. Nature Genet. 16, 307-310 (1997).
100. Mundlos, S. et al. Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia. Cell 89, 773-779 (1997).
101. Laurent, M. N., Blitz, I. L., Hashimoto, C., Rothbacher, U. & Cho, K. W. The Xenopus homeobox gene twin mediates Wnt induction of goosecoid in establishment of Spemann's organizer. Development 124, 4905-4916 (1997).
102. Henry, G. L. & Melton, D. A. Mixer, a homeobox gene required for endoderm development. Science 281, 91-96 (1998).
103. Huse, M., Chen, Y. G., Massagué, J. & Kuriyan, J. Crystal structure of the cytoplasmic domain of the type I TGF-β receptor in complex with FKBP12. Cell 96, 425-436 (1999).
104. Shi, Y., Hata, A., Lo, R. S., Massagué, J. & Pavletich, N. P. A structural basis for mutational inactivation of the tumour suppressor SMAD4. Nature 388, 87-93 (1997).
105. Wu, G. et al. Structural basis of SMAD2 recognition by the SMAD Anchor for Receptor Activation. Science 287, 92-97 (2000).
106. Kim, J., Johnson, K., Chen, H. J., Carroll, S. & Laughon, A. Drosophila Mad binds to DNA and directly mediates activation of vestigial by Decapentaplegic. Nature 388, 304-308 (1997).
107. Liu, F. et al. A human Mad protein acting as a BMP-regulated transcriptional activator. Nature 381, 620-623 (1996).
108. Dou, C. et al. BF-1 interferes with transforming growth factor-β signaling by associating with SMAD partners. Mol. Cell. Biol. 20, 6201-6211 (2000).
109. Kim, R. H. et al. A novel SMAD nuclear interacting protein, SNIP1, suppresses p300-dependent TGF-β signal transduction. Genes Dev. 14, 1605-1616 (2000).